Abbvie.mediaroom.com

Abb Vie Mediaroom. , News, January 28, 2026 January 16, 2026 Press Kits Our press kits are designed to provide journalists with a broad range of background...

Never miss Abbvie.mediaroom.com updates: Start reading the news feed of Abb Vie Mediaroom right away! This site’s feed is stale or rarely updated (or it might be broken for a reason), but you may check related news or Abbvie.mediaroom.com popular pages instead. It is generally safe for browsing, so you may click any item to proceed to the site.

News, stories and media buzz related to Abb Vie Mediaroom

Subscribe to related news

Big Pharma quietly enlists leading professors to justify $1,000-per-day drugs
via patriotrising

Over the last three years, pharmaceutical companies have mounted a public relations blitz to tout new cures for the hepatitis C virus and persuade insurers, including government programs such as Medicare and Medicaid, to cover the costs. That isn’t an...
Hepatitis C Drug Market: expanding in Asia Pacific, Latin America and Middle East & Africa due to prevalence of the ...
via bostonprwire

Zion Research has published a new report titled “Hepatitis C Drug Market for (Hospitals, Private Labs, Physician Offices, Public Health Labs and Blood Banks) by Application – Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2...
Heartbeat Ideas and Heartbeat West to Join Saatchi & Saatchi Health Agencies in U.S.
via heartbeatideas

Paris, October 30, 2013 — Publicis Groupe [Euronext Paris: FR0000130577, CAC 40] (Paris:PUB) announced today that Heartbeat Ideas, one of the largest and most highly regarded digital agencies in the healthcare communications space, has joined the...
JMP Security’s Michael King Jr.: Use Stock Volatility to Invest in Innovative Oncology Companies
via vantagewire

Recent stock market volatility is an opportunity for biotech investors to pick up great stocks before market caps rise substantially. In this interview with The Life Sciences Report, Michael King Jr. of JMP Securities predicts an ongoing bull market...
Fujifilm's second Arrow declaration survives AbbVie's strike out application as Humira biosimilar battle rages on
via ipkitten.blogspot

The AmeriKat normally needs to swim around in coffee to wake up, but Mr Justice Arnold's decision had the same impact this morning... This morning Mr Justice Arnold handed down his decision in Fujifilm Kyowa v AbbVie [2016] EWHC 2204 dismissing AbbVie...

Abbvie.mediaroom.com popular pages

AbbVie News Center - News

News January 28, 2026 January 16, 2026 Press Kits Our press kits are designed to provide journalists with a broad range of background information on our company. January 28, 2026 January 1...
AbbVie Announces Michael Severino, M.D. to Lead R&D Organization and Drive Continued Pipeline Advancement - May 15, 2014

AbbVie (NYSE: ABBV) has named Michael Severino, M.D. its new Executive Vice President, Research and Development (R&D) and Chief Scientific Officer. Dr. Severino's track record of innovation within...

Infinity And AbbVie Announce Global Strategic Collaboration To Develop And Commercialize Duvelisib (IPI-145) In Oncology - Sep 3

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) and AbbVie Inc. (NYSE: ABBV) today announced that they have entered into a global collaboration to develop and commercialize duvelisib (IPI-145),...